Center for Stem Cell and Translational Immunotherapy (CSTI)

Brigham and Women's Hospital, Harvard Medical School

Publications 2009 – 2005

| 2020 thru 2018 | 2017 thru 2015 | 2014 thru 2010 | 2009 | 2008 | 2007 | 200620052004 thru 2001 |


Sasportas LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JA, Mohapatra G, Figueiredo JL, Martuza RL, Weissleder R and Shah K. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. PNAS  USA. 2009 doi: 10.1073/pnas.0806647106. PMID: 19264968

Yoo BK, Gredler R, Vozhilla N, Su ZZ, Chen D, Forcier T, Shah K, Saxena U, Hansen U, Fisher PB and Sarkar D. Identification of genes conferring resistance to 5-fluorouracil. PNAS  USA. 2009 doi: 10.1073/pnas.0901451106. PMID: 19622726

Wakimoto H, Kesari S, Farrell CJ, Curry WT, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL and Rabkin SD. Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors. Cancer Research. 2009 doi: 10.1158/0008-5472.CAN-08-3886. PMID: 19351838

Piccirillo SG, Binda E, Fiocco R, Vescovi L and Shah K. Brain cancer stem cells. Journal of Molecular Medicine (Berlin, Germany). 2009 doi: 10.1007/s00109-009-0535-3. PMID: 19784875

Kumar AT, Chung E, Raymond SB, van de Water JA, Shah K, Fukumura D, Jain RK, Bacskai BJ and Boas DA. Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast. Optic Letters. 2009 doi: 10.1364/ol.34.002066. PMID:19572001

Shah K. Imaging neural stem cell fate in mouse model of glioma. Current Protocols in Stem Cell Biology. 2009 doi: 10.1002/9780470151808.sc05a01s8.  PMID: 19306259


Corsten MF and Shah K. Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncology. 2008 doi: 10.1016/S1470-2045(08)70099-8. PMID: 18374291

Shah K, Hingtgen S, Kasmieh R, Figueiredo JL, Garcia-Garcia E, Martinez-Serrano A, Breakefield X and Weissleder R. Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. Journal of Neuroscience. 2008 doi: 10.1523/JNEUROSCI.0296-08.2008. PMID: 18434519

Hingtgen S, Ren X, Terwilliger E, Classon M, Weissleder R and Shah K. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide. Molecular Cancer Therapeutics. 2008 doi: 10.1158/1535-7163. PMID: 19001440 

Hink M, Shah K, Russinova E, de Vries S and Visser AJ. Fluorescence Fluctuation Analysis of Arabidopsis Thaliana Somatic Embryogenesis Receptor-Like Kinase and Brassinosteroid Insensitive 1 Receptor Oligomerization. Biophysical Journal. 2007 doi: 10.1529/biophysj.107.112003. PMID: 17905839

Dent P, Yacoub A, Park M, Sarkar D, Shah K, Curiel DT, Grant S and Fisher PB. Searching for a cure: Gene therapy for glioblastoma. Cancer Biology & Therapy. 2008 doi: 10.4161/cbt.7.9.6408. PMID: 18708757

Yacoub A, Hamed H, Emdad L, Dos Santos W, Gupta P, Broaddus WC, Ramakrishnan V, Sarkar D, Shah K, Curiel DT, Grant S, Fisher PB and Dent P. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. Cancer Biology & Therapy. 2008 doi: 10.4161/cbt.7.6.5928. PMID: 18376144

Yip S and Shah K. Stem-cell based therapies for brain tumors. Current Opinion in Molecular Therapeutics. 2008 10(4):334-42. PMID: 18683097

Deliolanis NC, Kasmieh R, Wurdinger T, Tannous BA, Shah K and Ntziachristos V. Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. Journal of Biomedical Optics. 2008 doi: 10.1117/1.2967184. PMID: 19021336 


Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R and Shah K. MicroRNA-21 Knockdown Disrupts Glioma Growth in Vivo and Displays Synergistic Cytotoxicity With Neural Precursor Cell Delivered S-TRAIL in Human Gliomas. Cancer Research. 2007 doi: 10.1158/0008-5472. PMID: 17908999

Arwert E, Hingtgen S, Figueiredo JL, Bergquist H, Mahmood U, Weissleder R and Shah K. Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo. Cancer Research. 2007 doi: 10.1158/0008-5472. PMID: 17671203

Kock N, Kasmieh R, Weissleder R and Shah K. Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL. Neoplasia. 2007 doi: 10.1593/neo.07223. PMID: 17534449


Shah K, Breakefield XO. HSV Amplicon Vectors for Cancer Therapy. Current Gene Therapy. 2006 doi: 10.2174/156652306777592063. PMID: 16787187


Shah K, Bureau E, Kim DE, Yang K, Tang Y, Weissleder R and Breakefield XO. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. 2005 Annals of Neurology. doi: 10.1002/ana.20306. PMID: 15622535

Shah K, Tung CH, Breakefield XO and Weissleder R. In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Molecular Therapy. 2005 doi: 10.1016/j.ymthe.2005.01.017. PMID: 15922963

Shah K and Weissleder R. Molecular Optical Imaging: Applications Leading to the Development of Present Day Therapeutics. NeuroRx. 2005 doi: 10.1602/neurorx.2.2.215. PMID: 15897946

Shah K. Current Advances in Molecular Imaging of Gene and Cell Therapy for Cancer. Cancer Biology & Therapy. 2005 doi: 10.4161/cbt.4.5.1706.  PMID: 15908803

[aps-social id=”1″]

Scroll to top